Нажмите на эту строку чтобы перейти к Новостям сайта "Русский врач"

Перейти
на сайт
журнала
"Врач"
Перейти на сайт журнала "Медицинская сестра"
Перейти на сайт журнала "Фармация"
Перейти на сайт журнала "Молекулярная медицина"
Перейти на сайт журнала "Вопросы биологической, медицинской и фармацевтической химии"
Журнал включен в российские и международные библиотечные и реферативные базы данных

ВАК (Россия)
РИНЦ (Россия)
Эко-Вектор (Россия)

EFFECT OF ACTG(4-7)-PRO-GLY-PRO AND ACTG(6-9)-PRO-GLY-PRO ON THE INTENSITY OF REDOX PROCESSES AND BEHAVIOURAL STATUS OF RATS UNDER THYROID HYPERFUNCTION CONDITIONS

DOI: https://doi.org/10.29296/25877313-2024-03-08
Issue: 
3
Year: 
2024

M.U. Sergalieva
Ph.D. (Biol.), Associate Professor of the Department of Pharmacognosy, Pharmaceutical Technology and Biotechnology,
Astrakhan State Medical University of the Ministry of Health of Russia (Astrakhan, Russia)
E-mail: charlina_astr@mail.ru
A.A. Tsibizova
Ph.D. (Pharm.), Associate Professor of the Department of Pharmacognosy, Pharmaceutical Technology and Biotechnology,
Astrakhan State Medical University of the Ministry of Health of Russia (Astrakhan, Russia)
V.Kh. Murtalieva
Assistant of the Department of Pharmacognosy, Pharmaceutical Technology and Biotechnology,
Astrakhan State Medical University of the Ministry of Health of Russia (Astrakhan, Russia)
L.A. Andreeva
Deputy Head of the Laboratory of Molecular Pharmacology of Peptides, National Research Center,
Institute of Molecular Genetics of the National Research Centre «Kurchatov Institute» (Moscow, Russia)
N.F. Myasoedov
Dr.Sc. (Chem.), Professor, Academician of the Russian Academy of Sciences,
Institute of Molecular Genetics, National Research Centre «Kurchatov Institute» (Moscow, Russia)
M.A. Samotrueva
Dr.Sc. (Med.), Professor, Head of the Department of Pharmacognosy, Pharmaceutical Technology and Biotechnology,
Astrakhan State Medical University of the Ministry of Health of Russia (Astrakhan, Russia)

The aim of the work is to study the effect of melanocortins on the intensity of redox processes in the prefrontal region of the brain and the behavioral status of rats against the background of thyroid hyperfunction. Material and methods. In the experiment, the test animals were divided into the following groups (n = 10): intact rats (control); animals treated with sodium salt pentahydrate L-thyroxine (hyperthyroidism); rats receiving ACTH (4-7)-Pro-Gly-Pro and individuals receiving ACTH (6-9)-Pro-Gly-Pro, re-spectively, intraperitoneally daily for 21 days, starting from day 22 of administration of sodium salt pentahydrate L-thyroxine. Hyperthyroidism was simulated in animals by intragastric administration of L-thyroxine sodium salt pentahydrate for 42 days. The intensity of lipoperoxidation processes was studied by the content of diene and triene conjugates in the prefrontal zone tissue, the initial level of TBА-reactive products, and the rates of spon-taneous and ascorbic peroxidation of lipids. The level of protein peroxidation products was determined by the reaction of oxidized amino acid residues of proteins with 2,4-dinitrophenyl hydrazone. Evaluation of the enzymatic unit of the antioxidant system of the prefrontal region was carried out by de-termining the activity of superoxide dismutase and catalase. The behavioral status of laboratory rodents was studied using the «Hole board» test. Results. The use of ACTH(4-7)-Pro-Gly-Pro and ACTH(6-9)-Pro-Gly-Pro compounds under experimental hyperthyroidism led to a decrease in the intensity of the processes of peroxidation of lipids, proteins and the restoration of levels of activity of antioxidant enzymes – superoxide dismutase and catalase in the tissue of the prefrontal region of the brain of animals, as well as correction behavioral indicators in the «Hole board» test. Conclusion. The obtained experimental data indicate that ACTH(4-7)-Pro-Gly-Pro and ACTH(6-9)-Pro-Gly-Pro show antiperoxy and antioxidant activity against lipoperoxidation parameters and oxidative modification of proteins and enzymatic protection systems in the prefrontal brain zone tissue, as well as exert psychocorregating action on behavioral responses of white rats against the background of thyroid hyperfunction.

Keywords: 
hyperthyroidism
melanocortins
semax
behavior
antioxidant activity
psychocorrective activity.

References: 
  1. Hernandez A. Cognitive function in hypothyroidism: what is that deiodinase again? Journal of Clinical Investigation. 2019; 129(1): 55–57. DOI: 10.1172/JCI125203.
  2. Li L., Zhi M., Hou Z. et al. Abnormal brain functional connectivity leads to impaired mood and cognition in hyperthyroidism: A rest-ing-state functional MRI study. Oncotarget. 2017; 8(4): 6283–6294. DOI: 10.18632/oncotarget.14060.
  3. Villanueva I., Alva-Sánchez C., Pacheco-Rosado J. The role of thy-roid hormones as inductors of oxidative stress and neurodegenera-tion. Oxid Med Cell Longev. 2013; 2013: 218145. DOI: 10.1155/2013/218145.
  4. Флейшман М.Ю., Толстенок И.В., Иннокентьев А.А. Влияние пептида «Селанк» на уровень окислительного стресса в головном мозге и тонкой кишке белых крыс на модели черепно-мозговой травмы. Сибирский научный медицинский журнал. 2019; 39(2): 46–51. DOI: 10.15372/SSMJ20190205 (Flejshman M.Ju., Tolstenok I.V., Innokent'ev A.A. Vlijanie pepti-da «Selank» na uroven' okislitel'nogo stressa v golovnom mozge i tonkoj kishke belyh krys na modeli cherepno-mozgovoj travmy. Sibirskij nauch-nyj medicinskij zhurnal. 2019; 39(2): 46–51. DOI: 10.15372/SSMJ20190205).
  5. Vorvul A.O., Bobintsev I.I., Svishcheva M.V. et al. ACTH4-7-PGP peptide corrects behaviour and corticosterone level in rats under chronic stress. Russian Phy. J. named after I.M. Sechenov. 2021; 107(11): 1359–1371. DOI: 10.31857/S0869813921110108.
  6. Борозденко Д.А., Ляхман Д.Н., Голубев Я.В. и др. Изу-чение фармакокинетики и нейропротекторной актив-ности нового производного 4-фенилпирролидинона-2 в модели ишемическо-го инсульта на животных. Вестник РГМУ. 2020; 1: 51–58. DOI: 10.24075/vrgmu.2020.010 (Borozdenko D.A., Ljahman D.N., Golubev Ja.V. i dr. Izu-chenie farmakokinetiki i nejroprotektornoj aktivno-sti novogo proizvodnogo 4-fenilpirrolidinona-2 v modeli ishemicheskogo insul'ta na zhivotnyh. Vestnik RGMU. 2020; 1: 51–58. DOI: 10.24075/vrgmu.2020.010).
  7. Chainy G.B., Sahoo D.K. Hormones and oxidative stress: an over-view. Free Radical Research. 2020; 54(1): 1–26. DOI: 10.1080/10715762.2019.1702656.
  8. Saklani P., Khan H., Gupta S. et al. Neuropeptides: Potential neu-roprotective agents in ischemic injury. Life Sciences. 2022; 288: 120186. DOI: 10.1016/j.lfs.2021.120186.
  9. Ben-Shushan S., Miller Y. Neuropeptides: Roles and activities as metal chelators in neurodegenerative diseases. The Journal of Phys-ical Chemistry B. 2021; 125(11): 2796–2811. DOI: 10.1021/acs.jpcb.0c11151.
  10. Dergunova L.V., Filippenkov I.B., Limborska S.A. et al. Pharma-cotranscriptomics of peptide drugs with neuroprotective properties Med Res Rev. 2021; 41(2): 754–769. DOI: 10.1002/med.21704.
  11. Vorvul A.O., Bobyntsev I.I., Medvedeva O.A. et al. Effects of His-Phe-Arg-Trp-Pro-Gly-Pro peptide on free-radical oxidation pro-cesses in conditions of chronic restraint stress. Bulletin of RSMU. 2021; (6): 61–66. DOI: 10.24075/brsmu.2021.056.